日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol

慢性粒单核细胞白血病中TET2基因突变数量(1个、2个或≥3个):共突变模式及其在包括BLAST-mol和CPSS-mol在内的现代预后模型中的预后意义

Yousuf, Muhammad; Fathima, Saubia; Alsugair, Ali Khalid A; Wu, Samuel J; Abdelmagid, Maymona G; Patel, Shraddha P; Faldu, Priyansh C; Abdelaziz, Rania M; Csizmar, Clifford M; Mangaonkar, Abhishek A; Zepeda Mendoza, Cinthya J; Reichard, Kaaren K; Viswanatha, David S; He, Rong; Pardanani, Animesh; Gangat, Naseema; Patnaik, Mrinal S; Tefferi, Ayalew

Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System

910例系统性肥大细胞增生症患者的预后:国际共识分类在梅奥联盟预后系统中的预后贡献

Aperna, Fnu; Abdelmagid, Maymona G; Kumar, Mahesh; Butterfield, Joseph H; Pongdee, Thanai; Arana Yi, Cecilia Y; Patnaik, Mrinal S; Arber, Daniel A; Orazi, Attilio; Chen, Dong; Reichard, Kaaren K; Gangat, Naseema; Pardanani, Animesh; Tefferi, Ayalew

UNISOM: Unified Somatic Calling and Machine Learning-based Classification Enhance the Discovery of CHIP

UNISOM:统一体细胞呼叫和基于机器学习的分类增强了染色体异常的发现

Tian, Shulan; Jenkinson, Garrett; Ferrer, Alejandro; Yan, Huihuang; Morales-Rosado, Joel A; Wang, Kevin L; Lasho, Terra L; Yan, Benjamin B; Baheti, Saurabh; Olson, Janet E; Baughn, Linda B; Ding, Wei; Slager, Susan L; Patnaik, Mrinal S; Lazaridis, Konstantinos N; Klee, Eric W

A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis

克隆性造血治疗干预和早期临床试验的蓝图

Haque, Tamanna; Shastri, Aditi; Desai, Pinkal; Xie, Zhuoer; Hammond, Danielle; King, Zoe; Kishtagari, Ashwin; Madanat, Yazan F; Abaza, Yasmin; Silver, Alexander J; Singh, Abhay; Borate, Uma M; Heimlich, J Brett; Slosky, David A; Bolton, Kelly L; Patnaik, Mrinal S; Bick, Alexander G; Verma, Amit K; Jaiswal, Siddhartha; Steensma, David P; Savona, Michael R

Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

更正:在三级医疗保健系统中实施罕见病基因组医学:梅奥诊所罕见病和未确诊疾病项目 (PRaUD)

Pinto E Vairo, Filippo; Kemppainen, Jennifer L; Vitek, Carolyn R Rohrer; Whalen, Denise A; Kolbert, Kayla J; Sikkink, Kaitlin J; Kroc, Sarah A; Kruisselbrink, Teresa; Shupe, Gabrielle F; Knudson, Alyssa K; Burke, Elizabeth M; Loftus, Elle C; Bandel, Lorelei A; Prochnow, Carri A; Mulvihill, Lindsay A; Thomas, Brittany; Gable, Dale M; Graddy, Courtney B; Garzon, Giovanna G Moreno; Ekpoh, Idara U; Porquera, Eva M Carmona; Fervenza, Fernando C; Hogan, Marie C; El Ters, Mireille; Warrington, Kenneth J; Davis, John M 3rd; Koster, Matthew J; Orandi, Amir B; Basiaga, Matthew L; Vella, Adrian; Kumar, Seema; Creo, Ana L; Lteif, Aida N; Pittock, Siobhan T; Tebben, Peter J; Abate, Ejigayehu G; Joshi, Avni Y; Ristagno, Elizabeth H; Patnaik, Mrinal S; Schimmenti, Lisa A; Dhamija, Radhika; Sabrowsky, Sonia M; Wierenga, Klaas J; Keddis, Mira T; Samadder, Niloy Jewel J; Presutti, Richard J; Robinson, Steven I; Stephens, Michael C; Roberts, Lewis R; Faubion, William A Jr; Driscoll, Sherilyn W; Wong-Kisiel, Lily C; Selcen, Duygu; Flanagan, Eoin P; Ramanan, Vijay K; Jackson, Lauren M; Mauermann, Michelle L; Ortega, Victor E; Anderson, Sarah A; Aoudia, Stacy L; Klee, Eric W; McAllister, Tammy M; Lazaridis, Konstantinos N

Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival

急性髓系白血病中不良核型亚型在突变组成和移植后生存率方面表现出显著差异。

Tefferi, Ayalew; Singh, Amritpal; Gangat, Naseema; Al-Kali, Aref; Alkhateeb, Hassan; Shah, Mithun; Patnaik, Mrinal S; Elliott, Michelle A; Hogan, William J; Litzow, Mark R; Wolanskyj-Spinner, Alexandra; Hook, Christopher C; Mangaonkar, Abhishek; Viswanatha, David; Chen, Dong; Pardanani, Animesh; Begna, Kebede H; Ketterling, Rhett P

Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival

既往接受过鲁索替尼治疗的急变期骨髓增生性肿瘤:突变和生存率的比较分析

Abdelmagid, Maymona G; Al-Kali, Aref; Begna, Kebede H; Hogan, William J; Litzow, Mark R; Fleti, Farah; Mangaonkar, Abhishek A; Patnaik, Mrinal S; Elliott, Michelle A; Alkhateeb, Hassan; Shi, Min; Howard, Matthew T; Reichard, Kaaren K; Ketterling, Rhett P; Shah, Mithun; Pardanani, Animesh; Gangat, Naseema; Tefferi, Ayalew

Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

在三级医疗保健系统中实施基因组医学治疗罕见病:梅奥诊所罕见病和未确诊疾病项目 (PRaUD)

Pinto E Vairo, Filippo; Kemppainen, Jennifer L; Vitek, Carolyn R Rohrer; Whalen, Denise A; Kolbert, Kayla J; Sikkink, Kaitlin J; Kroc, Sarah A; Kruisselbrink, Teresa; Shupe, Gabrielle F; Knudson, Alyssa K; Burke, Elizabeth M; Loftus, Elle C; Bandel, Lorelei A; Prochnow, Carri A; Mulvihill, Lindsay A; Thomas, Brittany; Gable, Dale M; Graddy, Courtney B; Garzon, Giovanna G Moreno; Ekpoh, Idara U; Porquera, Eva M Carmona; Fervenza, Fernando C; Hogan, Marie C; El Ters, Mireille; Warrington, Kenneth J; Davis, John M 3rd; Koster, Matthew J; Orandi, Amir B; Basiaga, Matthew L; Vella, Adrian; Kumar, Seema; Creo, Ana L; Lteif, Aida N; Pittock, Siobhan T; Tebben, Peter J; Abate, Ejigayehu G; Joshi, Avni Y; Ristagno, Elizabeth H; Patnaik, Mrinal S; Schimmenti, Lisa A; Dhamija, Radhika; Sabrowsky, Sonia M; Wierenga, Klaas J; Keddis, Mira T; Samadder, Niloy Jewel J; Presutti, Richard J; Robinson, Steven I; Stephens, Michael C; Roberts, Lewis R; Faubion, William A Jr; Driscoll, Sherilyn W; Wong-Kisiel, Lily C; Selcen, Duygu; Flanagan, Eoin P; Ramanan, Vijay K; Jackson, Lauren M; Mauermann, Michelle L; Ortega, Victor E; Anderson, Sarah A; Aoudia, Stacy L; Klee, Eric W; McAllister, Tammy M; Lazaridis, Konstantinos N

A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature

一例伴有嗜酸性粒细胞增多和酪氨酸激酶基因融合的髓系/淋巴系肿瘤患者的TRIP11::FLT3基因融合:病例报告及文献复习

Venable, Elise R; Gagnon, Marie-France; Pitel, Beth A; Palmer, Jeanne M; Peterson, Jess F; Baughn, Linda B; Hoppman, Nicole L; Greipp, Patricia T; Ketterling, Rhett P; Patnaik, Mrinal S; Kelemen, Katalin; Xu, Xinjie

Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience

梅奥诊所回顾性分析:柔红霉素-60、柔红霉素-90 和伊达比星-12 用于急性髓系白血病诱导化疗的疗效比较

Tefferi, Ayalew; Gangat, Naseema; Shah, Mithun; Alkhateeb, Hassan; Patnaik, Mrinal S; Al-Kali, Aref; Elliott, Michelle A; Hogan, William J; Litzow, Mark R; Hook, Christopher C; Mangaonkar, Abhishek; Viswanatha, David; Chen, Dong; Pardanani, Animesh; Ketterling, Rhett P; Begna, Kebede H